|
Table 1. Demographic and clinical features, lifetime comorbidity, |
|
|
Age, mean (SD) |
14.9 (3.1) |
|
< 13 years, n (%) |
20 (46.5) |
|
From 13 to 18 years, n (%) |
23 (53.9) |
|
Sex Male subjects, n (%) Female subjects, n (%) |
26 (60.5) 17 (39.5) |
|
Lifetime comorbidity, n (%) |
|
|
Obsessive–compulsive disorder |
26 (44.2) |
|
Social phobia |
17 (39.5) |
|
Panic disorder or agoraphobia |
11 (25.6) |
|
Separation anxiety disorder |
7 (16.3) |
|
Generalized anxiety disorder |
8 (18.6) |
|
Attention-deficit hyperactivity disorder or |
12 (27.9) |
|
Age at onset, mean (SD) |
|
|
Bipolar disorder |
12.27 (2.94) |
|
Obsessive–compulsive disorder |
9.63 (2.71) |
|
Social phobia |
6.62 (1.74) |
|
Panic disorder or agoraphobia |
10.27 (4.62) |
|
Separation anxiety |
6.12 (2.69) |
|
Generalized anxiety disorder |
8.62 (1.99) |
|
Attention-deficit hyperactivity disorder or |
4.2 (0.63) |
|
Comorbid anxiety disorders, mean (SD) |
1.41(1.18) |
|
None, n (%) |
10 (23.5) |
|
1 |
15 (34.9) |
|
2 or more |
18 (41.6) |
|
Comorbid disorders, mean (SD) |
1.81 (1.5) |
|
None, n (%) |
5 (11.6) |
|
1 |
18 (41.9) |
|
2 or more |
20 (46.5) |
|
CGI-Severity, mean (SD) |
4.85 (0.78) |
aCGI-Severity = Clinical Global Impression-Severity